Gardy Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

United statesAakash patelNovo nordiskGardy healthAnnual scientific sessionAmerican collegeCardiovascular outcomesPeople with overweightHeart failureProjected marketPharma analystHeart failureClinical trial